The afternoon of August 18th, Vice Chairman of the Banking and Insurance Regulatory Commission Liang Tao and Director of the Provincial Banking and Insurance Regulatory Bureau Zhou Jialong inspected Anhui Biochem, First-Class Counsel of Financial Rights Protection Bureau of the Banking and Insurance Regulatory Commission Luo Qing, Second-Class Counsel of Statistics, IT & Risk Surveillance Department of the Banking and Insurance Regulatory Commission Liu Zhongrui, Director of Financial Rights Protection Bureau of the Banking and Insurance Regulatory Commission Zhao Xin, Member of the General Office of the Banking and Insurance Regulatory Commission He Xiaoshuai, Deputy Director of Provincial Banking and Insurance Regulatory Bureau Shi Qiwu, Deputy Chief of IT & Risk Surveillance Department of the Banking and Insurance Regulatory Bureau Fang Hejin, Deputy Director of the High-tech District Management Committee Luo Min and President of the Bank of Hangzhou-Hefei Branch Liang Zhong accompanied the visit.

President Wang accompanied Chairman Liang and other senior leaders to the Second Class Gene Cell Laboratory of Anhui Biochem and introduced the latest progress of the oncolytic virus project. 

In the specially held investigative meeting, Chairman Liang inquired the progress of national funding and financial policies in enterprise and asked in detail the funding issues facing the enterprise. 

President Wang reported in detail the support of banking agencies towards Anhui Biochem post the epidemic, highlighting the role of low interest subsidized loans  and refinancing played in lowering financial cost.

President Wang also proposed several advice: including transforming to reasonable supervision, supporting industrial enterprise, enhancing project loans, offering transition period for refinancing and innovating the scope of pledges to truly support enterprise development. 

Chairman Liang highly accredited Anhui Biochem of the efforts made towards national major disease and appreciated President Wang for thinking at a height for other enterprise. Finally, Director Zhou and other officials offered authoritative guidance to the issues proposed by our company. 

Vice President Wang Zhe, Vice President Cai Wei and General Manager of Anhui Biochem Bio-pharmaceutical Co.，Ltd attended the meeting as well.